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Despite the proliferation of antismoking campaigns and lung cancer screening by computed tomography, lung cancer remains the leading cause of cancer death worldwide. Because of the anatomical features of the lung, the growth patterns of lung malignancies differ from malignancies of other sites. The patterns of lung cancer progression are cancer spread via vascular, lymphatic, or alveolar spaces (1) . These are related to the biological behavior of the lung tumor. Regarding lung cancer prognosis, histopathological findings that include grade of differentiation (2) , pleural invasion (3, 4) , and lymphovascular invasion (5, 6) have been reported to be prognostic factors. The spread of lung cancer to the alveolar spaces was recently reported as a novel pattern of cancer progression, and reports on lung adenocarcinoma have shown that cancer spread through the air spaces (STAS) is a significant risk factor for recurrence and a poor prognostic factor for overall survival (1,7-15) ( Table 1) . As an aggressive manifestation of lung cancer, STAS was introduced as a new concept for lung adenocarcinoma in the 2015 World Health Organization (WHO) classification (16) . WHO classification defined STAS as "micropapillary clusters, solid nests, or single cells spreading within air spaces beyond the edge of the main tumor" (16) .
The 1995 Atlas of Tumor Pathology recognized aerogenous spread as the presence of isolated clusters of tumor cells in the alveolar space (17) , but at that time, aerogenous spread was underrated and had not been well studied. In 2015, Kadota et al. revealed that STAS was a significant risk factor for recurrence in patients with ≤2-cm stage I lung adenocarcinoma who underwent limited resection, wedge resection, or segmentectomy (8) . Interestingly, they also showed that STAS was not related to recurrence in patients who underwent lobectomy. Onozato et al. reported that patients with lung adenocarcinomas and tumor islands (alternative term for "STAS"), which are large clusters of tumor cells in alveolar spaces, had a significantly worse prognosis than patients with lung adenocarcinomas without tumor islands (7) . They showed that adenocarcinomas with tumor islands were more likely to be found in smokers, to show predominant solid or micropapillary growth patterns, and tended to have KRAS mutations. Furthermore, Warth et al. evaluated 569 resected lung adenocarcinomas and found that 288 of them (50.6%) showed STAS. They found that STAS was detected at high rates in men and in patients with adenocarcinomas with wild-type epidermal growth factor receptors, lymph node metastasis, distant metastasis, and advanced-stage lung cancer (1). Morimoto et al. investigated adenocarcinomas with a micropapillary component and studied the relationship between free tumor cell clusters and outcome (9) . Instead of the term "STAS", they described "free tumor clusters (FTC)" and explained that FTC did not contain solid nests or single cells. Locoregional recurrence was frequently observed in patients with FTC and in those patients with shorter recurrence-free survival. They concluded that FTC had a negative impact on the postoperative outcome of patients with micropapillarypositive adenocarcinomas.
STAS is related to recurrence and survival in patients STAS could be associated with local recurrence after limited resection. Other investigators whose work was described earlier in this article (7, 8, 15) found that lobectomy reduced the risk of locoregional recurrence in patients with STAS. Masai et al. performed multivariate analysis that revealed that STAS and width of the surgical margin were significant risk factors of recurrence (15) . The mechanisms involved in the spread of cancer cells to air spaces are largely unknown. In terms of cell connections, a cell adhesion molecule such as epithelial (E)-cadherin or ICAM is thought to be associated with STAS. However, the decreased expression of epithelial (E)-cadherin has been reported to be unrelated to STAS (21) . STAS might occur as a result of a surgical procedure or tumor biopsy, which leads to disruption of the resected tumor by manipulation. To examine this hypothesis, we determined the proportions of patients who developed STAS after different surgical procedures. We could not find differences in the rates of STAS between surgical procedures (10). However, it is speculated that preoperative biopsy procedures might lead to STAS.
There is a possibility that STAS can occur as an artifact during the processing of surgical specimens for histopathological evaluation. One report described the concept of "spreading through a knife surface (STAKS)" (22) . STAKS is considered to be an artifact resulting from specimen processing. Since, in general, the steps in processing tissues and making slides are not standardized or recorded, verifying that STAKS can lead to observations of STAS is difficult. Despite the opinions that STAS is an artifact, many recent reports have confirmed the significant effects of STAS on the recurrence of lung cancer and survival. Kadota et al. described detailed methods for differentiating STAS from alveolar macrophages and artifacts (8, 14) . Dai et al. used the methods of Kadota and found similar results (13) . I think that STAS is not artifact.
Dai et al. have reported that patients with adenocarcinomas ranging in size from <2 to 3 cm that showed STAS had an unfavorable outcome similar to the outcome of stage IB patients with or without STAS. The differences between overall survival and recurrence-free survival in patients with ≤2-cm adenocarcinomas with and without STAS were not significant (13) . The authors suggested that STAS might be a factor to include in a staging system. While the TNM classification categorizes the tumor into stages based on the anatomical extent of tumor, histopathological factors such as lymphatic, venous, and perineural invasion are included in staging systems (23) . In lung cancer, pleural invasion is only the histopathological factor that affects the T factor. However, pleural invasion is difficult to diagnose by hematoxylin and eosin staining, and instead should be evaluated on tissue preparations stained for elastic tissues. By contrast, STAS can be diagnosed on routine preparations stained by hematoxylin and eosin, indicating that diagnosing STAS should be easier than diagnosing pleural invasion.
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